Caryn Domenici, RPh
Advertisement
Articles by Caryn Domenici, RPh
Trilipix has been approved by the FDA, the first and only fibrate indicated for use in combination with a statin for cholesterol management.
This single, longer-acting R-enantiomer of the racemic modafinil has been approved as a wakefulness-promoting drug.
This novel agent for HIV patients received accelerated FDA approval.
This drug is a novel single-entity tablet, combining a dihydropyridine calcium channel blocker and an angiotensin receptor blocker.
Ms. Domenici and Dr. Patel are both pharmacists at Brigham and Women's Hospital, Boston, Mass.
Ms. Domenici and Dr. Patel are both pharmacists at Brigham and Women's Hospital, Boston, Mass.
Ms. Domenici and Dr. Patel are both pharmacists at Brigham and Women's Hospital, Boston, Mass. Ms. Aiello is a sixth-year PharmD candidate from Massachusetts College of Pharmacy currently on clinical clerkship in the Investigational Drug Service at Brigham and Women's Hospital.
Advertisement
Latest Updated Articles
- Rx PRODUCT NEWS PROFILE: A Closer Look at New FDA Actions: Nucynta
September 15th 2009
- Rx Product News Profile: A Closer Look at New FDA Actions: Creon
August 15th 2009
- Rx Product News: Profile: A Closer Look at New FDA Actions: Intelence
September 1st 2008
Advertisement
Advertisement
Trending on Pharmacy Times
1
Cyclosporiasis Cases Reach 5100: Investigators Zero In On Lettuce, Possible Taco Bell Link
2
Psychedelics in Cluster Headaches Are Breaking the Pain Cycle
3
Subcutaneous Olanzapine in Schizophrenia: Expanding the Utility of a Proven Therapy
4
Patient-Reported Outcomes, Machine Learning May Predict Breast Cancer Recurrence Earlier
5